Ovoca Bio (LSE:OVB) Total Liabilities : £0.73 Mil (As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Ovoca Bio Total Liabilities?

Ovoca Bio's Total Liabilities for the quarter that ended in Jun. 2024 was £0.73 Mil.

Ovoca Bio's quarterly Total Liabilities increased from Jun. 2023 (£0.70 Mil) to Dec. 2023 (£0.83 Mil) but then declined from Dec. 2023 (£0.83 Mil) to Jun. 2024 (£0.73 Mil).

Ovoca Bio's annual Total Liabilities increased from Dec. 2021 (£1.14 Mil) to Dec. 2022 (£1.54 Mil) but then declined from Dec. 2022 (£1.54 Mil) to Dec. 2023 (£0.83 Mil).

Ovoca Bio Total Liabilities Historical Data

The historical data trend for Ovoca Bio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Total Liabilities Chart

Ovoca Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

0.36

0.44

1.14

1.54

0.83

Ovoca Bio Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial															2.35	1.54	0.70	0.83	0.73

Ovoca Bio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ovoca Bio's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.833	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.83

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2.988	-	2.155
	=	0.83

Ovoca Bio's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.73	+	(0	+	-0.001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.73

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	2.624	-	1.894
	=	0.73

Ovoca Bio Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (LSE:OVB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OVXA:Ireland OVB.GB:UK

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.